Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial.
Loriot Y, Miller K, Sternberg CN, Fizazi K, De Bono JS, Chowdhury S, Higano CS, Noonberg S, Holmstrom S, Mansbach H, Perabo FG, Phung D, Ivanescu C, Skaltsa K, Beer TM, Tombal B. Loriot Y, et al. Among authors: skaltsa k. Lancet Oncol. 2015 May;16(5):509-21. doi: 10.1016/S1470-2045(15)70113-0. Epub 2015 Apr 14. Lancet Oncol. 2015. PMID: 25888263 Clinical Trial.
The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies.
Beer TM, Miller K, Tombal B, Cella D, Phung D, Holmstrom S, Ivanescu C, Skaltsa K, Naidoo S. Beer TM, et al. Among authors: skaltsa k. Eur J Cancer. 2017 Dec;87:21-29. doi: 10.1016/j.ejca.2017.09.035. Epub 2017 Oct 31. Eur J Cancer. 2017. PMID: 29096157 Clinical Trial.
Results and implications of using a new eq-5d value set for cost-utility analyses in sweden. An application using enzalutamide (xtandi®) verse best supportive care for treatment of metastatic castration resistant prostate cancer (MCRPC).
Ghatnekar O, Nørgaard K, Skaltsa K. Ghatnekar O, et al. Among authors: skaltsa k. Value Health. 2014 Nov;17(7):A648. doi: 10.1016/j.jval.2014.08.2350. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202332 Free article. No abstract available.
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
Weiss J, Goldschmidt J, Andric Z, Dragnev KH, Gwaltney C, Skaltsa K, Pritchett Y, Antal JM, Morris SR, Daniel D. Weiss J, et al. Among authors: skaltsa k. Clin Lung Cancer. 2021 Sep;22(5):449-460. doi: 10.1016/j.cllc.2021.03.010. Epub 2021 Mar 26. Clin Lung Cancer. 2021. PMID: 33895103 Free article.
Decision Drivers For Brazil: An Analysis of Conitec Recommendations.
Kreeftmeijer J, Skaltsa K, Palazzolo D. Kreeftmeijer J, et al. Among authors: skaltsa k. Value Health. 2014 Nov;17(7):A439. doi: 10.1016/j.jval.2014.08.1145. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201172 Free article. No abstract available.
22 results